Obsessive-Compulsive Disorder Market Growth
A study by Nakajima A. et al.,(2018), quoted that Obsessive-compulsive disorder (OCD) is a relatively common and frequently debilitating neuropsychiatric disorder that affects approximately 2% of the general population in Japan.
According to a study titled “Women Are at Greater Risk of Obsessive-Compulsive Disorder Than Men: A Meta-Analytic Review of OCD Prevalence Worldwide'' conducted by Fawcettet E. J. al.,(2020), the overall aggregate current, period, and lifetime OCD prevalence estimates were 1.1%, 0.8%, and 1.3%, respectively.
DelveInsight's "Obsessive-Compulsive Disorder Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Obsessive-Compulsive Disorder Market, historical and forecasted epidemiology, the pipeline insight as well as the Obsessive-Compulsive Disorder market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Obsessive-Compulsive Disorder Market Growth Analysis
The Obsessive-Compulsive Disorder market size is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of some emerging therapies during the forecast period.
The Obsessive-Compulsive Disorder market analysis section of the report helps to build a detailed comprehension of the historic, current, and forecasted Obsessive-Compulsive Disorder market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers and demand for better technology.
Obsessive-Compulsive Disorder Epidemiology Forecast
The Obsessive-Compulsive Disorder epidemiology section covers insights about historical and current Obsessive-Compulsive Disorder patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Obsessive-Compulsive Disorder Pipeline Analysis
The Obsessive-Compulsive Disorder Pipeline and Drugs Uptake section focus on the rate of uptake of the potential drugs recently launched in the Obsessive-Compulsive Disorder market or expected to get launched in the market during the study period. The analysis covers the Obsessive-Compulsive Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.
Some of the key companies in the Obsessive-Compulsive Disorder market include:
Pfize
GlaxoSmithKline
Eli Lilly and Company
Biohaven Pharmaceuticals
And others.
Obsessive-Compulsive Disorder Therapies Covered in the report include ZOLOFT, Paxil, PROZAC, Trigriluzole, and many others.
Source: Obsessive-Compulsive Disorder Market Growth